The prevalence of comorbidities in Danish patients with obesity – A Danish register-based study based on data from 2002 to 2018

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

The prevalence of comorbidities in Danish patients with obesity – A Danish register-based study based on data from 2002 to 2018. / Pedersen, Mikkel H.; Bøgelund, Mette; Dirksen, Carsten; Johansen, Pierre; Jørgensen, Nils B.; Madsbad, Sten; Pantin, Ulrik H.

In: Clinical obesity, Vol. 12, No. 5, e12542, 2022.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Pedersen, MH, Bøgelund, M, Dirksen, C, Johansen, P, Jørgensen, NB, Madsbad, S & Pantin, UH 2022, 'The prevalence of comorbidities in Danish patients with obesity – A Danish register-based study based on data from 2002 to 2018', Clinical obesity, vol. 12, no. 5, e12542. https://doi.org/10.1111/cob.12542

APA

Pedersen, M. H., Bøgelund, M., Dirksen, C., Johansen, P., Jørgensen, N. B., Madsbad, S., & Pantin, U. H. (2022). The prevalence of comorbidities in Danish patients with obesity – A Danish register-based study based on data from 2002 to 2018. Clinical obesity, 12(5), [e12542]. https://doi.org/10.1111/cob.12542

Vancouver

Pedersen MH, Bøgelund M, Dirksen C, Johansen P, Jørgensen NB, Madsbad S et al. The prevalence of comorbidities in Danish patients with obesity – A Danish register-based study based on data from 2002 to 2018. Clinical obesity. 2022;12(5). e12542. https://doi.org/10.1111/cob.12542

Author

Pedersen, Mikkel H. ; Bøgelund, Mette ; Dirksen, Carsten ; Johansen, Pierre ; Jørgensen, Nils B. ; Madsbad, Sten ; Pantin, Ulrik H. / The prevalence of comorbidities in Danish patients with obesity – A Danish register-based study based on data from 2002 to 2018. In: Clinical obesity. 2022 ; Vol. 12, No. 5.

Bibtex

@article{53b32f3b8d3440e194bd0de5e409585e,

title = "The prevalence of comorbidities in Danish patients with obesity – A Danish register-based study based on data from 2002 to 2018",

abstract = "We used the Danish National Health Registers to conduct a study on the prevalence of obesity-related comorbidities in Danish citizens who have been diagnosed with obesity at a Danish hospital. This was a retrospective observational study with a population comprising all Danish citizens (≥18 years) who have been registered with a specific obesity class diagnosis in the Danish National Patient Register between 2002 and 2018. A total of 86 980 persons with hospital-diagnosed obesity were included in the study population. To investigate how the risk of having comorbidities varies with the degree of obesity, we applied adjusted logistic regression to estimate the odds ratio of having one of the following predefined comorbidities for people with a BMI in obesity classes II and III compared with people with a BMI in obesity class I: type 2 diabetes, ischaemic heart disease, non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, hip and knee osteoarthritis, obstructive sleep apnoea and asthma. Comorbidities were defined from ICD-10 diagnosis codes and prescription medication utilization. The odds ratio for obstructive sleep apnoea (OR 1.86 and OR 3.0), type 2 diabetes (OR 1.68 and OR 2.26), hip and knee osteoarthritis (OR 1.29 and OR 1.54) and asthma (OR1.13 and OR 1.25) increased significantly with obesity class (obesity class II relative to I and III relative to I, respectively). The odds ratio of having had at least one comorbidity was estimated to be 1.52 for people with a BMI in obesity class II and 2.10 for people with a BMI in obesity class III compared with people in obesity class I. The risk of obstructive sleep apnoea, type 2 diabetes, hip and knee osteoarthritis, and asthma increased significantly with increasing BMI, highlighting the importance of preventing further weight gain even in individuals who are already living with obesity.",

keywords = "burden of illness, comorbidities, obesity",

author = "Pedersen, {Mikkel H.} and Mette B{\o}gelund and Carsten Dirksen and Pierre Johansen and J{\o}rgensen, {Nils B.} and Sten Madsbad and Pantin, {Ulrik H.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.",

year = "2022",

doi = "10.1111/cob.12542",

language = "English",

volume = "12",

journal = "Clinical Obesity",

issn = "1758-8103",

publisher = "Wiley-Blackwell",

number = "5",

}

RIS

TY - JOUR

T1 - The prevalence of comorbidities in Danish patients with obesity – A Danish register-based study based on data from 2002 to 2018

AU - Pedersen, Mikkel H.

AU - Bøgelund, Mette

AU - Dirksen, Carsten

AU - Johansen, Pierre

AU - Jørgensen, Nils B.

AU - Madsbad, Sten

AU - Pantin, Ulrik H.

PY - 2022

Y1 - 2022

N2 - We used the Danish National Health Registers to conduct a study on the prevalence of obesity-related comorbidities in Danish citizens who have been diagnosed with obesity at a Danish hospital. This was a retrospective observational study with a population comprising all Danish citizens (≥18 years) who have been registered with a specific obesity class diagnosis in the Danish National Patient Register between 2002 and 2018. A total of 86 980 persons with hospital-diagnosed obesity were included in the study population. To investigate how the risk of having comorbidities varies with the degree of obesity, we applied adjusted logistic regression to estimate the odds ratio of having one of the following predefined comorbidities for people with a BMI in obesity classes II and III compared with people with a BMI in obesity class I: type 2 diabetes, ischaemic heart disease, non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, hip and knee osteoarthritis, obstructive sleep apnoea and asthma. Comorbidities were defined from ICD-10 diagnosis codes and prescription medication utilization. The odds ratio for obstructive sleep apnoea (OR 1.86 and OR 3.0), type 2 diabetes (OR 1.68 and OR 2.26), hip and knee osteoarthritis (OR 1.29 and OR 1.54) and asthma (OR1.13 and OR 1.25) increased significantly with obesity class (obesity class II relative to I and III relative to I, respectively). The odds ratio of having had at least one comorbidity was estimated to be 1.52 for people with a BMI in obesity class II and 2.10 for people with a BMI in obesity class III compared with people in obesity class I. The risk of obstructive sleep apnoea, type 2 diabetes, hip and knee osteoarthritis, and asthma increased significantly with increasing BMI, highlighting the importance of preventing further weight gain even in individuals who are already living with obesity.

AB - We used the Danish National Health Registers to conduct a study on the prevalence of obesity-related comorbidities in Danish citizens who have been diagnosed with obesity at a Danish hospital. This was a retrospective observational study with a population comprising all Danish citizens (≥18 years) who have been registered with a specific obesity class diagnosis in the Danish National Patient Register between 2002 and 2018. A total of 86 980 persons with hospital-diagnosed obesity were included in the study population. To investigate how the risk of having comorbidities varies with the degree of obesity, we applied adjusted logistic regression to estimate the odds ratio of having one of the following predefined comorbidities for people with a BMI in obesity classes II and III compared with people with a BMI in obesity class I: type 2 diabetes, ischaemic heart disease, non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, hip and knee osteoarthritis, obstructive sleep apnoea and asthma. Comorbidities were defined from ICD-10 diagnosis codes and prescription medication utilization. The odds ratio for obstructive sleep apnoea (OR 1.86 and OR 3.0), type 2 diabetes (OR 1.68 and OR 2.26), hip and knee osteoarthritis (OR 1.29 and OR 1.54) and asthma (OR1.13 and OR 1.25) increased significantly with obesity class (obesity class II relative to I and III relative to I, respectively). The odds ratio of having had at least one comorbidity was estimated to be 1.52 for people with a BMI in obesity class II and 2.10 for people with a BMI in obesity class III compared with people in obesity class I. The risk of obstructive sleep apnoea, type 2 diabetes, hip and knee osteoarthritis, and asthma increased significantly with increasing BMI, highlighting the importance of preventing further weight gain even in individuals who are already living with obesity.

KW - burden of illness

KW - comorbidities

KW - obesity

U2 - 10.1111/cob.12542

DO - 10.1111/cob.12542

M3 - Journal article

C2 - 35768944

AN - SCOPUS:85146781079

VL - 12

JO - Clinical Obesity

JF - Clinical Obesity

SN - 1758-8103

IS - 5

M1 - e12542

ER -

ID: 344854455